Some patient populations may respond better to Atezolizumab and other checkpoint inhibitors

Some patient populations may respond better to Atezolizumab and other checkpoint inhibitors

AnnualMeeting2016

3 years
389 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Evan Yu, MD of Seattle Cancer Care Alliance notes that some patient populations may respond better to atezolizumab and other checkpoint inhibitors
Up Next Autoplay